000 01395 a2200325 4500
005 20250516220103.0
264 0 _c20150708
008 201507s 0 0 eng d
022 _a1522-1539
024 7 _a10.1152/ajpheart.00209.2014
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAroor, Annayya R
245 0 0 _aPleiotropic effects of the dipeptidylpeptidase-4 inhibitors on the cardiovascular system.
_h[electronic resource]
260 _bAmerican journal of physiology. Heart and circulatory physiology
_cAug 2014
300 _aH477-92 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
650 0 4 _aAnimals
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aDipeptidyl-Peptidase IV Inhibitors
_xpharmacology
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aGlucagon-Like Peptide 1
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIncretins
_xmetabolism
650 0 4 _aMetabolic Diseases
_xdrug therapy
700 1 _aSowers, James R
700 1 _aJia, Guanghong
700 1 _aDeMarco, Vincent G
773 0 _tAmerican journal of physiology. Heart and circulatory physiology
_gvol. 307
_gno. 4
_gp. H477-92
856 4 0 _uhttps://doi.org/10.1152/ajpheart.00209.2014
_zAvailable from publisher's website
999 _c23919245
_d23919245